(Q40964677)

25 September 2017

1 reference

title

Divining the serpin inhibition mechanism: a suicide substrate 'springe'? (English)

1 reference

25 September 2017

0 references

Engh RA

1

1 reference

25 September 2017

Huber R

series ordinal

2

1 reference

25 September 2017

Bode W

series ordinal

3

1 reference

25 September 2017

Schulze AJ

series ordinal

4

1 reference

25 September 2017

1 December 1995

1 reference

25 September 2017

Trends in Biotechnology

1 reference

25 September 2017

13

1 reference

25 September 2017

12

1 reference

25 September 2017

503-510

1 reference

Structural aspects of serpin inhibition

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

What do dysfunctional serpins tell us about molecular mobility and disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Natural protein proteinase inhibitors and their interaction with proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Effect of single amino acid replacements on the thermodynamics of the reactive site peptide bond hydrolysis in ovomucoid third domain

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Refined X-ray crystal structures of the reactive site modified ovomucoid inhibitor third domains from silver pheasant (OMSVP3*) and from Japanese quail (OMJPQ3*)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Crystal structure of plakalbumin, a proteolytically nicked form of ovalbumin. Its relationship to the structure of cleaved alpha-1-proteinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Crystal structure of ovalbumin as a model for the reactive centre of serpins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Structural basis of latency in plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Conformational Studies on Plasminogen Activator Inhibitor (PAI-1) in Active, Latent, Substrate, and Cleaved Forms

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Mobile reactive centre of serpins and the control of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Mutations which impede loop/sheet polymerization enhance the secretion of human alpha 1-antitrypsin deficiency variants.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Biological implications of a 3 A structure of dimeric antithrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Structural transition of alpha 1-antitrypsin by a peptide sequentially similar to beta-strand s4A.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Evidence for the extent of insertion of the active site loop of intact alpha 1 proteinase inhibitor in beta-sheet A

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Inhibitory activity and conformational transition of alpha1-proteinase inhibitor variants

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Alpha 1-proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Modulation of protein C inhibitor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Regulation of thrombin activity by antithrombin and heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Determination of the vitronectin binding site on plasminogen activator inhibitor 1 (PAI‐1)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Inhibition of acrosin by serpins. A suicide substrate mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Immunologic evidence for insertion of the reactive-bond loop of antithrombin into the A beta-sheet of the inhibitor during trapping of target proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Sodium dodecyl sulfate-stable complexes between serpins and active or inactive proteinases contain the region COOH-terminal to the reactive site loop

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Interaction of human α-1-antitrypsin with porcine trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Trypsin complexed with alpha 1-proteinase inhibitor has an increased structural flexibility

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Structure of an acyl-enzyme intermediate during catalysis: (guanidinobenzoyl)trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Molecular evolution of plasminogen activator inhibitor-1 functional stability

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Serpin-resistant mutants of human tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Development of a novel recombinant serpin with potential antithrombotic properties

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Kinetics of the Interaction of alpha-Chymotrypsin with Trypsin Kallikrein Inhibitor (Kunitz) in Which the Reactive-Site Peptide Bond Lys-15-Ala-16 is Split

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

Structural basis for serpin inhibitor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2989013-7

7 January 2021

10.1016/S0167-7799(00)89013-7

Identifiers

DOI

1 reference

25 September 2017

1 reference